Credit Agricole’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$779K Hold
28,800
﹤0.01% 1128
2025
Q4
$1.23M Buy
+28,800
New +$1.09M ﹤0.01% 990

Other funds holding RIGL

Credit Agricole's RIGL Position: Q1 2026 in Review

Credit Agricole held its Rigel Pharmaceuticals (RIGL) position steady in Q1 2026 at 28,800 shares worth $779K. The position accounts for ﹤0.01% of the portfolio, ranked #1128.

Credit Agricole first reported a position in RIGL in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.23M in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Credit Agricole held 28,800 shares of Rigel Pharmaceuticals worth $779K as of Q1 2026.
  • Credit Agricole left its Rigel Pharmaceuticals share count unchanged in Q1 2026.
  • Rigel Pharmaceuticals made up ﹤0.01% of Credit Agricole's portfolio in Q1 2026, its #1128 holding.
  • Credit Agricole first reported a position in Rigel Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Credit Agricole's Rigel Pharmaceuticals position peaked at $1.23M in Q4 2025.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.